Learn about why not all eye plaques used for treatment of choroidal melanoma and other intraocular tumors are not equal. Dr. Finger started using palladium-103 seed sources in eye plaques back in 1991. He recognized that palladium-103 would provide more radiation to choroidal melanomas while reaching fewer normal vital intraocular structures compared to iodine-125 seeds. This difference has translated into better local cancer destruction and better vision retention for his patients.
Paul T. Finger, MD, FACS The New York Eye Cancer Center 115 East 61st Street New York City, New York, USA 10065 E-mail: pfinger@eyecancer.com Telephone: (011) 212 832 8170
Information
- Show
- PublishedFebruary 17, 2020 at 5:30 AM UTC
- Length8 min
- Episode6
- RatingClean